TScan Therapeutics, Inc. (TCRX)
1.07
+0.04
(+3.88%)
USD |
NASDAQ |
Dec 11, 16:00
1.075
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Profit Margin (Quarterly): -1.42K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Geron Corp. | -39.02% |
| Novavax, Inc. | -287.3% |
| XOMA Royalty Corp. | -- |
| SELLAS Life Sciences Group, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.23% |
| Return on Assets | -44.21% |
| Return on Invested Capital | -48.24% |
| Gross Profit Margin (Quarterly) | 69.45% |
| Operating Margin (Quarterly) | -1.48K% |
| Return on Net Operating Assets | -204.2% |